ChemoTech appoints local CFO for the Indian operations

We have the honour to welcome Mr. Prabhat Rastogi, as the newly appointed CFO for ChemoTech in India. Prabhat is a Qualified Chartered Accountant with over 32 years of experience in various industries, of which he has been working for the past 19 years in the healthcare industry. He has a rich experience in setting up and building organizations and co-managing medium sized organizations. 

- After having successfully worked together for another Swedish enterprise in India, for more than a decade, I am pleased to welcome Prabhat to the folds of Scandinavian ChemoTech AB and Scandinavian Meditech. Our battle against the “Emperor of Maladies” is a great mountain to climb, for which we need some of the best people on board. His deep insight into the operational realities of doing business in India, will go a long way into building a great support system for our Indian Operations, says Ashim Purohit, Chairman of ChemoTech’s Indian Operations.

For more information, please contact:

Mohan Frick, CEO
+ 46 (0)10-218 93 02, 

Scandinavian ChemoTech AB (publ)

ChemoTech is a young and dynamic life science corporation which rests on a great medical expertise and technical knowledge. Our latest launch of the IQWaveTM is an innovation in electrochemotherapy, which gently provides an utmost effective treatment of many types of tumors. ChemoTech’s stocks (CMOTEC B) are listed at NASDAQ First North in Stockholm and Västra Hamnen Corporate Finance AB is the company’s Certified Adviser.